Effects of tyramine administration in Pa
โ
J. Antonelle deMarcaida; Steven R. Schwid; William B. White; Karen Blindauer; St
๐
Article
๐
2006
๐
John Wiley and Sons
๐
English
โ 76 KB
## Abstract Rasagiline is a novel, potent, and selective MAOโB inhibitor shown to be effective for Parkinson's disease. Traditional nonselective MAO inhibitors have been associated with dietary tyramine interactions that can induce hypertensive reactions. To test safety, tyramine challenges (50โ75